U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Showing 1 - 4 of 4 results

Status:
US Approved Rx (1995)
First approved in 1995

Class (Stereo):
CHEMICAL (ABSOLUTE)



Lamivudine is a reverse transcriptase inhibitor used alone or in combination with other classes of anti-human immunodeficiency virus (HIV) drugs in the treatment of HIV infection. This molecule has two stereo-centers, thus giving rise to four stereoi...
Status:
Other

Class (Stereo):
CHEMICAL (ABSOLUTE)

Conditions:

(+)-cis-Lamivudine is an enantiomer of lamivudine, considered to be impurity. Lamivudine is a reverse transcriptase inhibitor used alone or in combination with other classes of anti-human immunodeficiency virus (HIV) drugs in the treatment of HIV inf...
Status:
US Approved Rx (1995)
First approved in 1995

Class (Stereo):
CHEMICAL (RACEMIC)



Lamivudine is a reverse transcriptase inhibitor used alone or in combination with other classes of anti-human immunodeficiency virus (HIV) drugs in the treatment of HIV infection. This molecule has two stereo-centers, thus giving rise to four stereoi...
Status:
US Approved Rx (1995)
First approved in 1995

Class (Stereo):
CHEMICAL (ABSOLUTE)



Lamivudine is a reverse transcriptase inhibitor used alone or in combination with other classes of anti-human immunodeficiency virus (HIV) drugs in the treatment of HIV infection. This molecule has two stereo-centers, thus giving rise to four stereoi...